ArticlePloS one2014

The relevance of external quality assessment for molecular testing for ALK positive non-small cell lung cancer: results from two pilot rounds show room for optimization.

Lien Tembuyser et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.